Shanghai Younuojian Biotechnology

Unogen is a clinical-stage biopharmaceutical company based in Shanghai, China, specializing in the development of innovative macromolecular drugs for autoimmune and inflammatory diseases. The company leverages its proprietary mammalian cell expression and protein engineering platforms to create a pipeline of high-quality biologics, including monoclonal antibodies and fusion proteins. Its lead programs target well-validated pathways such as IL-17 and IL-4R to treat conditions like psoriasis and atopic dermatitis. Unogen aims to provide affordable, high-efficacy therapeutic solutions for patients with chronic immunological disorders through efficient R&D and manufacturing processes.